We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

Find a share

Search for UK shares

Search

Market movers

United Kingdom
movers are constituents of the FTSE 350.
% GainersCompany
content
IC ViewLastChange
Afren PLC
AFR:LSE
107.33
GBX
+3.83
+3.70%
Countrywide PLC
CWD:LSE
468.00
GBX
+16.60
+3.68%
Mitchells & Butlers PLC
MAB:LSE
367.60
GBX
+9.90
+2.77%
Lancashire Holdings Ltd
LRE:LSE
653.00
GBX
+13.00
+2.03%
Royal Mail PLC
RMG:LSE
395.55
GBX
+3.35
+0.85%
Foxtons Group PLC
FOXT:LSE
219.10
GBX
+4.10
+1.91%
Oxford Instruments PLC
OXIG:LSE
1,034.59
GBX
+14.59
+1.43%
St. Modwen Properties PLC
SMP:LSE
370.60
GBX
+3.60
+0.98%
Hiscox Ltd
HSX:LSE
638.00
GBX
+8.00
+1.27%
Spire Healthcare Group PLC
SPI:LSE
292.30
GBX
+3.00
+1.04%
As of Oct 01 2014 16:45 BST.

Companies news

Who bought who
Deal status
Deal value
Date
Aeon Co LtdacquiredDaiei IncAnnounced262.19m24 Sep 2014
1-1 of 1 results

Companies news

Financial Times articles may require a separate login and/or subscription to FT.com

GM eyes near-doubling of profit margins
Fink blames regulators for heated markets
New York and London vie for world title
UBM plans rights issue to buy Advanstar
Ivascyn: Pimco’s straight talking CIO

Featured company

Epistem Holdings PLCEHP:LSE

Epistem Holdings Plc (Epistem) is a United Kingdom-based biotechnology company focusing on epithelial stem cells in the areas of oncology, gastrointestinal disease, dermatology and ageing

© Thomson Reuters Click for restrictions.

All markets data located on Investors Chronicle is subject to the Investors Chronicle Terms & Conditions.

All content on Investors Chronicle is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Investors Chronicle and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Conditions.

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply